SEC Form 4 · accession 0001209191-17-046206
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Salvatore Privitera
Officer — Chief Technology Officer
Period of report
Jul 24, 2017
Accepted (ET)
Jul 25, 2017 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 24, 2017 | A | 60,000 | $0.00 | A | 66,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. Amended and Restated 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant.